- Home » News and Events

NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Agrees to Acquire Dry Powder Inhaler Spray Drying, Capsule Manufacturing, and Packaging Capabilities from Acorda Therapeutics
Jan 13, 2021
Catalent has entered into a definitive agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics, Inc. (Nasdaq: ACOR), a developer of therapies to restore function and improve the lives of people with neurological disorders.
Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program
Dec 21, 2020
Novan today announced an agreement with Catalent for the development of an intranasal formulation of berdazimer sodium for use in Novan’s COVID-19 program.
Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan
Dec 10, 2020
Catalent today announced the appointment of Nakaya “Nick” Matsumaru as General Manager of its new clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products
Dec 7, 2020
Passage Bio, Inc. and Catalent today announced that manufacturing operations have commenced to support adeno-associated virus (AAV) production for Passage Bio’s lead gene therapy product candidates for the treatment of rare monogenic CNS disorders.
Catalent to Invest $10 Million to Expand High Potency Containment Capabilities for Micronization
Dec 3, 2020
Catalent today announced that it is investing $10 million in isolator capabilities at its sites in Malvern, Pennsylvania and Dartford, U.K., to expand its micronization capabilities for highly potent drug compounds.
Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO™ (pralsetinib)
Nov 23, 2020
Catalent today announced that it had entered into a commercial supply agreement with Blueprint Medicines following FDA approval of GAVRETO™ (pralsetinib).
Catalent Appoints Dr. Behzad Mahdavi as Vice President of Open Innovation, Biologics, Cell and Gene Therapy
Nov 19, 2020
Catalent appoints Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy. Dr. Mahdavi will join a team of experts to accelerate the adoption of new development and drug delivery technologies, and scalable manufacturing processes and techniques.
Catalent Completes Acquisition of Cell Therapy Manufacturing Facility from Bone Therapeutics
Nov 16, 2020
Catalent has completed the acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), including all of its assets located in Gosselies, Belgium.
Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent
Nov 5, 2020
Taysha Gene Therapies and Catalent today announced a partnership to support the development and manufacturing of Taysha’s gene therapies at Catalent’s Maryland-based gene therapy facilities.
Webinar: Are Real-Time Gene Therapy Test Results Possible?
Date: January 26, 2021
Webinar: Strategies for the Optimal Scale-up & Tech Transfer of Oral Small Molecules
Date: January 27, 2021
WCBP 2021
Date: January 25-28 & February 1-4, 2021
Navigating the Path to the Clinic and Beyond for Gene Therapies
Date: February 2, 2021
Webinar: Innovative Solutions to Meet the Complex Pharmaceutical Supply Challenges
Date: January 26, 2021
CAR-TCR Digital Summit Europe
Date: February 16-18, 2021
Webinar: Strategies for Integrating Business, Regulatory and Scientific Needs of CMC Clients
Date: February 18, 2021
Gene Therapy for Rare Disorders
Date: February 22-25, 2021
Early Phase Biologic Development: Upstream and Downstream Processes Considerations
Date: February 23, 2021
World ADC Europe 2021
Date: March 8-11, 2021
ISBiotech – 10th Spring Meeting Redux
Date: March 15-17, 2021
12th Global Drug Delivery & Formulation (DDF) Summit
Date: March 15-17, 2021
BEBPA US Bioassay Conference
Date: March 22-25, 2021
CTS Europe
Date: March 24-25, 2021
Clinical Trial Supply Roundtable Forum 2021
Date: March 30, 2021
Cell Gene Meeting on the Med
Date: April 6-9, 2021
CASSS Bioassays Symposium 2021
Date: April 19-23, 2021
Formulation & Delivery Series Europe
Date: April 20-21, 2021